About Biosyntech
Biosyntech is a company based in Laval (Canada) founded in 1994 was acquired by Piramal Group in June 2010. Biosyntech has raised $1.4 million across 1 funding round from investors including Piramal Group, ProQuest Investments and Highland Capital Partners. Biosyntech operates in a competitive market with competitors including Augmenix, AmacaThera, QBiotics, MediWound and Ilya Pharma, among others.
- Headquarter Laval, Canada
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$1.4 M (USD)
in 1 rounds
-
Latest Funding Round
$1.4 M (USD), Series A
Jun 01, 2009
-
Investors
Piramal Group
& 4 more
-
Employee Count
Employee Count
-
Acquired by
Piramal Group
(Jun 22, 2010)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Biosyntech
Biosyntech has successfully raised a total of $1.4M through 1 strategic funding round. The most recent funding activity was a Series A round of $1.4 million completed in June 2009. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $1.4M
-
First Round
First Round
(01 Jun 2009)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2009 | Amount | Series A - Biosyntech | Valuation |
investors |
Investors in Biosyntech
Biosyntech has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Piramal Group, ProQuest Investments and Highland Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Venture capital investment and entrepreneur support services.
|
Founded Year | Domain | Location | |
|
VC firm focusing on life science sector
|
Founded Year | Domain | Location |
Investments & Acquisitions by Biosyntech
Financial Statements - Biosyntech
Biosyntech Comparisons
Competitors of Biosyntech
Biosyntech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Augmenix, AmacaThera, QBiotics, MediWound and Ilya Pharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Hydrogel spacers are provided for prostate cancer radiation therapy.
|
|
| domain | founded_year | HQ Location |
Injectable hydrogel platform developed for therapeutic medical applications.
|
|
| domain | founded_year | HQ Location |
Small molecules from plant extracts are developed for medical applications.
|
|
| domain | founded_year | HQ Location |
Enzymatic therapies for tissue repair and regeneration are developed.
|
|
| domain | founded_year | HQ Location |
Biological drugs for skin and mucosa wound treatment are developed.
|
|
| domain | founded_year | HQ Location |
Macrophage cell therapies are developed for inflammatory and liver diseases.
|
Latest news on Biosyntech
Frequently Asked Questions about Biosyntech
Biosyntech was founded in 1994 and raised its 1st funding round 15 years after it was founded.
Biosyntech is headquartered in Laval, Canada. It is registered at Laval, Quebec, Canada.
Biosyntech is a funded company, having raised a total of $1.4M across 1 funding round to date. The company's 1st funding round was a Series A of $1.4M, raised on Jun 01, 2009.
BioSyntech was founded in 1994 in Laval, Canada, as a biotechnology firm. Chitosan-based hydrogels, known as BST-Gel, were developed for cartilage repair and therapeutic agent delivery. These thermogels, liquid at low temperatures and solid at body temperature, were designed for injection or application to sites like damaged cartilage, bone, and chronic wounds. Bankruptcy was filed in May 2010, followed by acquisition by Piramal Healthcare in June 2010.
Biosyntech's top competitors include Ilya Pharma, AmacaThera and Augmenix.
Biosyntech has 5 investors. Key investors include Piramal Group, ProQuest Investments, Highland Capital Partners, Fonds de solidarite FTQ, and Pappas Capital.